首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human LOXL2 Recombinant Antibody

Anti-Human LOXL2 Recombinant Antibody

产品编号

YR1290

别名

科研级 Simtuzumab ( 辛妥珠单抗 ), Anti-LOXL2 Recombinant Antibody, Research Grade Simtuzumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Simtuzumab ( 辛妥珠单抗 ), Anti-LOXL2 Recombinant Antibody, Research Grade Simtuzumab
Catalog NumberYR1290
Molecular NameSimtuzumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG4 Kappa
FormulationPBS, pH7.5
BackgroundSimtuzumab (INN, formerly GS 6624) is a humanized monoclonal antibody designed for the treatment of fibrosis. It binds to LOXL2 and acts as an immunomodulator. In January 2016, Gilead Sciences terminated its Phase 2 clinical study in patients with idiopathic pulmonary fibrosis (IPF) due to lack of efficacy.
CAS Number1318075-13-6
ApplicationFCM, IP, ELISA, Neut, FuncS
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetLOXL2[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价